Pfizer Inc (NYSE:PFE) Declares Rosy Earnings and Gloomy Outlook, Shares Up - GSK, VTUS, NVS

Pompano Beach, FL -- (SBWIRE) -- 01/29/2013 -- On Tuesday, Drug manufacturing giant, Pfizer Inc (NYSE:PFE) announced experts targets toping fourth-quarter results, courtesy to improved sales in growing markets, but the drugmaker estimated that 2013 profits would be lesser than Wall Street has forecasted.

Should PFE a Buy or Sell Now? Find Out Here

Pfizer, the biggest US drug maker, reported that quarterly earnings augmented to $6.32 billion, or 86 cents a share, as it reported an increase from selling its nutritional products business to Swiss food groups Nestle SA (NESN.VX) for almost $12 billion in November.

Investors were pleased about rosy earnings by drug maker and Pfizer (NYSE:PFE) shares were changing hands up 2.83% at 11:01 AM EST.

At the current trading session, Pfizer Inc. (NYSE:PFE) shares are advanced +2.38% to $27.48 while the stocks are trading within the range of $26.94 – $27.52. In the past year, the stock has traded within a range of $20.75 – $27.52. Average daily trading volume is 32.42 million shares.

Will PFE Continue To Move Higher? Find Out Here

If we look at a few other stocks within industry, GlaxoSmithKline plc, Ventrus Biosciences Inc and Novartis AG are in the gainers list. Let’s have a quick look on their Market performance.

GlaxoSmithKline plc (ADR) (NYSE:GSK) shares are up +1.64% to $45.29 while the stock is trading within the range of $45.05 – $45.30 in the current trading session. In the last 12 months the shares have traded between $41.68 and $47.69. The average daily trading volume is 2.24 million shares.

For How Long GSK will Fight for Profitability? Read This Trend Analysis report

Ventrus Biosciences Inc (NASDAQ:VTUS) shares in the current session moved up +24.54% reaching $3.40. The stocks are trading in a range of $2.76– $3.92. In the last year the stock has moved within a range of $1.99 – $13.53. The Company’s average daily trading volume is 75,314 shares.

What was the Moving Force behind VTUS On Bullish Run? Read This Research Report

Another rival company, Novartis AG (ADR) (NYSE:NVS), is trading up +0.59% to $67.98. Intraday trading recorded the stock price in a range of $67.74 to $68.07. In the previous 52 weeks the stock’s price ranged between $51.20 and $68.43. Their average daily trading volume is 1.47 million shares.

For How Long NVS will Fight for Profitability? Read This Trend Analysis report

About No Limit Stocks
NOLIMITSTOCKS.com is made up of a team of professional analyst that possess over 30 years of expert, stock market experience. Our goal is to research thousands of companies and provide investors with the latest insights in the market with stocks that can make explosive profits. We study the hottest companies so you don't have to!

Our newsletter is always free to Join and offers a variety of useful investors tools that will help you break the limits! There will be no regrets!

Disclaimer:
The assembled information disseminated by nolimitstocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. nolimitstocks.com does expect that investors will buy and sell securities based on information assembled and presented in nolimitstocks.com. PLEASE always do your own due diligence, and consult your financial advisor.